MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
XERS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Xeris Biopharma Holdings (XERS) Ownership - Who owns Xeris Biopharma Holdings?

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
1375 West Fulton Street
Phone
+1 844 445-5704
Employees
377
Web
https://www.xerispharma.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
1.19B
P/E Ratio
98.29
Total Cash
111.75M
Projected Growth
N/A
Total Debt
258.55M
Revenue
314.85M
Risk (Beta)
0.77
Dividend Yield
N/A
Total Cash/Share
0.65
Total Debt/Equity
N/A
Revenue/Share
1.76 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
XERS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for XERS
A.I. Advisor
published General Information

General Information

a developer of ready-to-use, liquid-stable injectables

Industry PharmaceuticalsGeneric

Profile
Details
Industry
Pharmaceuticals Major
Address
1375 West Fulton Street
Phone
+1 844 445-5704
Employees
377
Web
https://www.xerispharma.com